Mereo BioPharma Group plc (MREO)
NASDAQ: MREO · Real-Time Price · USD
0.2966
-0.0044 (-1.46%)
Jun 26, 2026, 4:00 PM EDT - Market closed
Mereo BioPharma Group Market Cap
Mereo BioPharma Group has a market cap or net worth of $47.34 million as of June 26, 2026. Its market cap has decreased by -88.76% in one year.
Market Cap
47.34M
Enterprise Value
11.12M
1-Year Change
-88.76%
Ranking
Category
Stock Price
$0.30
Market Cap Chart
Since April 24, 2019, Mereo BioPharma Group's market cap has decreased from $124.83M to $47.34M, a decrease of -62.07%. That is a compound annual growth rate of -12.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2026 | 47.34M | -28.60% |
| Dec 31, 2025 | 66.31M | -87.77% |
| Dec 31, 2024 | 542.14M | 67.64% |
| Dec 29, 2023 | 323.39M | 269.38% |
| Dec 30, 2022 | 87.55M | -49.64% |
| Dec 31, 2021 | 173.85M | -28.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Apr 24, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Instil Bio | 50.59M |
| PDS Biotechnology | 49.90M |
| Dogwood Therapeutics | 49.77M |
| Apollomics | 48.31M |
| Eloxx Pharmaceuticals | 47.43M |
| KALA BIO | 47.40M |
| Veru Inc. | 47.19M |
| Actuate Therapeutics | 46.89M |